Quick Links

Breast and Gynecologic Cancer Research Group

To design, develop, implement and monitor research efforts for breast and gynecologic cancers in the areas of chemoprevention and nutrition. Other prevention strategies include pharmacologic, biologic and genetic interventions. Research in vaccines or immunologic interventions, cancer screening and early detection is also a priority.
To design, develop and implement research through clinical trials screening, testing and validating new technologies that identify and modify premalignant lesions.
To monitor clinical trials in order to develop agents using measures of efficacy that include modulation of surrogate endpoint biomarkers or cancer incidence reduction.
To interact and communicate with extramural and intramural investigators in other NCI divisions and organizations of the National Cancer Program.

Name/Email	Room/Phone
Terri Cornelison, MD, PhD tc82u@nih.gov	EPN 2128 301-402-3963
Kathleen Foster, RN, BA kf91d@nih.gov	EPN 2126 301-594-0915
Karen Johnson, PhD, MD, MPH kj80y@nih.gov	EPN 2124 301-402-3666
Diane Solomon, MD ds87v@nih.gov	EPN 2130 301-402-6211
Alexis Ware warea@mail.nih.gov	EPN 2123 301-435-8990

Phone Number: (301) 496-8526
Fax Number: (301) 480-9939

Breast and Gynecologic Cancer
Research Group, DCP, NCI
Executive Plaza North, Suite 2123
6130 Executive Blvd. MSC 7333
Bethesda, MD 20892-7333

Breast and Gynecologic Cancer
Research Group, DCP, NCI
Executive Plaza North, Suite 2123
6130 Executive Blvd.
Rockville, MD 20852